EXPO Exponent Inc stock chart & analysis
Conviction 17Consumer DiscretionaryScan · Fri, Nov 6, 2026Exponent Inc (EXPO) closed at $84.02 (-2.11%) on Nov 6, 2026. Price is above its 50-day and above its 200-day moving average. RSI(14) 70, RS Rating 90, -7.2% from its 52-week high, +20.9% year to date. Sector: Consumer Discretionary · Services-Management Consulting Services.
Financials as of Fri, Oct 2, 2026 · quarterly.
EXPO technical analysis
Trend
EXPO is in an uptrend: price is above the 50-day, which is above the 200-day moving average. It closed 17.1% above the 50-day ($71.74) and 25.7% above the 200-day ($66.85). ADX(14) at 48 points to a strong, established trend. It meets 6 of 8 trend-template criteria.
Momentum
RSI(14) is 70, in the bullish half of its range. The MACD histogram is positive. Its RS Rating of 90 puts its weighted 12-month performance ahead of about 90% of the US market.
Volume and volatility
Volume on the latest session ran 0.6× its 20-day average. It trades about $44.0M a day on average. ATR(14) is $2.67, 3.2% of price — its typical daily range. On-balance volume is trending up. Chaikin Money Flow (0.12) shows accumulation.
Key levels
The chart pattern's support is $65.41 and its resistance $74.55. The 52-week range is $51.91 to $90.51; price is 7.2% below the high and 61.8% above the low. The VWAP anchored at the 52-week high is $86.10, above price.
Performance
EXPO returned +4.7% (1 week), +20.4% (1 month), +24.4% (3 months), +36.8% (6 months), +14.0% (1 year), +20.9% (year to date).
About Exponent Inc
Exponent Inc is a science and engineering consulting firm that provides solutions to complex problems. The company's consultant team is composed of scientists, physicians, engineers, as well as business and regulatory consultants. The company currently operates through two segments. The engineering and other scientific segments, which account for the majority of revenue, provide servicing encompassing biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, etc. The environmental and health segment covers chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences and others. The company generates almost all of its revenues from America.
Services-Management Consulting Services · Listed 1985 · 1,013 employees
Congress activity
Disclosed STOCK Act trades in EXPO · 5 recent
| Member | Side | Amount | Traded | Filed | PTR |
|---|---|---|---|---|---|
 Lisa McClain house · R · MI · traded 2025-09-11 | Sell | $1K–$15K | 2025-09-11 | 2025-10-22 | |
Lisa McClain house · R · MI · traded 2025-08-13 | Buy | $1K–$15K | 2025-08-13 | 2025-09-12 | |
 Jefferson Shreve house · R · IN · traded 2025-05-12 | Sell | $15K–$50K | 2025-05-12 | 2025-06-22 | |
Jefferson Shreve house · R · IN · traded 2025-03-13 | Buy | $15K–$50K | 2025-03-13 | 2025-04-11 | |
Jefferson Shreve house · R · IN · traded 2025-02-24 | Buy | $15K–$50K | 2025-02-24 | 2025-03-09 |
Insider activity
SEC Form 4 transactions in EXPO · open-market 3 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Reiss Richard Group Vice President · Common Stock · 2026-11-03 | Sell | 1.28K | $111K | 2026-11-03 | 2026-11-04 |
Corrigan Catherine Chief Executive Officer · Common Stock · 2026-08-17 | Exercise | 2.38K | $69K | 2026-08-17 | 2026-08-18 |
Corrigan Catherine Chief Executive Officer · Common Stock · 2026-08-17 | Sell | 1.71K | $113K | 2026-08-17 | 2026-08-18 |
Corrigan Catherine Chief Executive Officer · Non-Qualified Stock Option (right to buy) · 2026-08-17 | Exercise | 2.38K | — | 2026-08-17 | 2026-08-18 |
Corrigan Catherine Chief Executive Officer · Common Stock · 2026-07-15 | Exercise | 2.38K | $69K | 2026-07-15 | 2026-07-17 |
Corrigan Catherine Chief Executive Officer · Common Stock · 2026-07-15 | Sell | 1.74K | $109K | 2026-07-15 | 2026-07-17 |
Corrigan Catherine Chief Executive Officer · Non-Qualified Stock Option (right to buy) · 2026-07-15 | Exercise | 2.38K | — | 2026-07-15 | 2026-07-17 |
Corrigan Catherine Chief Executive Officer · Incentive Stock Option (right to buy) · 2026-06-25 | Exercise | 7.87K | — | 2026-06-25 | 2026-06-29 |
Corrigan Catherine Chief Executive Officer · Common Stock · 2026-06-25 | Exercise | 7.87K | $200K | 2026-06-25 | 2026-06-29 |
RICHARDSON KAREN A Director · Restricted Stock Units · 2026-06-04 | Grant | 2.86K | — | 2026-06-04 | 2026-06-04 |
SEC filings
EDGAR filings in EXPO · 9 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, no credit card.
Start free — 7-day trial, no card →Free daily signals by email. Top 3 setups per lane after every close. No account needed.
Unsubscribe anytime · Privacy
Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.